Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis
Ping Xu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Yang Xia(Northcentral University), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Chao Tong(Children's Hospital of Chongqing Medical University), Osheiza Abdulmalik(Children's Hospital of Philadelphia), Robert C. Roach(University of Colorado Anschutz Medical Campus), Tingting Xie(Central South University), Monika Dzieciątkowska(University of Colorado Anschutz Medical Campus), Anren Song(The University of Texas Health Science Center), Yujin Zhang, Hongbo Qi(The Affiliated Yongchuan Hospital of Chongqing Medical University), Chang‐Han Chen(National Chi Nan University), Rodney E. Kellems(Baylor College of Medicine), Weiru Zhang(Central South University), Benjamin C. Brown(University of Colorado Denver)
Cited by 75
Related Papers
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
|JCI Insight|2020|600
Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
|Cancer Cell|2018|565
The 2018 Lake Louise Acute Mountain Sickness Score
|High Altitude Medicine & Biology|2018|562
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
|Proceedings of the National Academy of Sciences|2018|556